Search clinical trials for: Immunosuppressive Agents

Total 186818 results

Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Discontinuation or Continuation of Immunosuppressive Therapy in Participants With Chronic Graft Versus Host Disease

Chronic Graft Versus Host Disease

United States
Sun Yat-sen University

Recruiting

Multi-model Image of Immunosuppressive Agents in TAO

Thyroid Associated Ophthalmopathy

China
Fujian Medical University

Unknown

ATG-F VS ATG for the Prevention of GVHD

GVHD in the Setting of Haplo-HSCT

China
University of Minnesota
Genentech, Inc.

Completed

Studies of Kidney Transplant Outcome

Post-Transplant Infections | Thymoglobulin | Transplant Recipient (Kidney) | Steroid-Free Maintenance Immunosuppression

United States
Rigshospitalet, Denmark

Completed

Tumor Characteristics, Pre-transplant Treatments and Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma

Liver Transplantation
Ospedale San Raffaele
Juvenile Diabetes Research Foundation

Completed

Calcineurin Inhibitor (CNI)-Free Immunosuppressive Regimen in T1D Patients Receiving Islet Transplantation (ECIT-1)

Type 1 Diabetes

Italy, Switzerland
Spanish Network for Research in Infectious Diseases
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Unknown

Immunosupressive Treatment in COVID-19 Patients (SAM-COVID)

COVID-19 Infection

Spain
Imperial College Healthcare NHS Trust

Completed

Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation (TAESR)

Graft Rejection | End-stage Renal Failure

United Kingdom
Klemens Budde
Charite University, Berlin, Germany; DESCARTES Working Group On Transplantation and other collaborators

Unknown

Efficacy and Safety of a Reduced Immunosuppression vs. Standard Triple Therapy in Senior Renal Transplant Recipients (REDUCE)

Immunosuppression After Renal Transplantation
National Institute of Allergy and Infectious Diseases...
Clinical Trials in Organ Transplantation in Children

Completed

Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children

Liver Transplant | Kidney Transplant | Heart Transplant | EBV-Related PTLD | Small Intestine Transplant | PTLDs

United States
CytoMed & Beike

Unknown

Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis (hUC-MSC-SLE)

Lupus Nephritis

China
National Institute of Allergy and Infectious Diseases...
National Heart, Lung, and Blood Institute (NHLBI); Genentech, Inc.; Rho Federal... and other collaborators

Terminated

Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation

Cardiac Allograft Vasculopathy | Heart Transplant Recipients

United States
Albert Einstein Healthcare Network
Veloxis Pharmaceuticals

Active, not recruiting

Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant

Post Liver Transplant

United States
The Catholic University of Korea

Unknown

Withdrawal of Immunosuppression in Long Term Stable Liver Transplant Recipients (tolerance)

Liver Transplantation

Korea, Republic of
Children's Hospital of Fudan University

Recruiting

Combined Immunosuppression for Pediatric Crohn's Disease

Crohn Disease | Immunosuppression | Children, Only | Infliximab

China
University of Rome Tor Vergata

Completed

De Novo Metabolic Syndrome in Liver Transplant Patients After Immunosuppression Withdrawal

Single Transplant | 5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend IS

Italy
Chiesi Farmaceutici S.p.A.

Completed

The Adherence of Immunosuppressive Therapy Including Tacrolimus Once-daily in Italian Kidney Transplant Recipients

Kidney Transplant

Italy
Beijing 302 Hospital

Unknown

Human Mesenchymal Stem Cells Induce Liver Transplant Tolerance

Evidence of Liver Transplantation

China
Yonsei University

Not yet recruiting

Effect of Immunosuppression in IgA Nephropathy

Biopsy-proven IgA Nephropathy

Korea, Republic of
ORIOL BESTARD
Department of Health, Generalitat de Catalunya

Unknown

Individualization of the Immunological Risk Based on Selective Biomarkers in Living-donor Renal Recipients (BIOIMMUN)

Kidney Transplant Failure and Rejection

Spain
Medical University of Vienna

Active, not recruiting

Pilot Trial on Immunosuppression Modulation to Increase SARS-CoV-2 Vaccine Response in Kidney Transplant Recipients (BOOST_TX_SubA)

COVID-19

Austria
Central Hospital, Nancy, France

Active, not recruiting

Anti-HLA Immunization And Immunosuppressive Therapy Management In Kidney Transplant Patients Returning to Dialysis

Kidney Transplantation | Dialysis | Immunosuppressive Agents | HLA Sensitization

France
Tongji Hospital

Recruiting

Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease (FMT)

Crohn Disease

China
Assistance Publique - Hôpitaux de Paris
Novartis

Completed

The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients (EVERKYSTE)

Autosomal Dominant Polycystic Kidney Disease

France
Hannover Medical School

Unknown

Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal Transplant (BKVIRUS)

Virus Diseases | Disorder Related to Renal Transplantation | Immunosuppression Related Infectious Disease

Germany
Shanghai General Hospital, Shanghai Jiao Tong University...

Unknown

Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients

Acute Myeloid Leukemia | Disorder Related to Bone Marrow Transplantation

China
Womb Transplant UK
Imperial College London

Unknown

Human Clinical Trial of Uterine Transplantation in the United Kingdom

Infertility
Wei Gao

Not yet recruiting

Efficacy and Safety of Immunosuppressive Withdrawal After Pediatric Liver Transplantation

Liver Transplant; Complications | Immunosuppression | Immune Tolerance

China
Washington University School of Medicine
Veloxis Pharmaceuticals

Recruiting

Once Daily Immunosuppression Regimen

Kidney Transplant; Complications

United States
Peking Union Medical College Hospital

Recruiting

Telitacicept in Primary APS Patients

Anti Phospholipid Syndrome

China
Sociedad Argentina de Reumatologia

Completed

Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection (SAR-COVID)

Rheumatic Diseases

Argentina
Lucie Heinzerling

Recruiting

Treatment of Immune-related Adverse Events Refractory to Standard Therapy and Associated Changes in Immunophenotype (PRIA)

Immune-related Adverse Event

Germany
Xiaoli Fan

Unknown

Plasma Exchange Combination of Immunosuppressive Regimens for Auto-immune Hepatitis

Hepatitis, Autoimmune

China
Assiut University

Unknown

Treatment Outcome of Uveitis in Autoimmune Diseases

Autoimmune Uveitis
University of Michigan Rogel Cancer Center

Completed

Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant

Multiple Myeloma | Lymphoma, Low-Grade | Lymphocytic Leukemia, Chronic

United States
National Institute of Diabetes and Digestive and...

Completed

Kidney Transplant for HIV-Infected Patients in Renal Failure

HIV Infection | Chronic Kidney Failure

United States
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Recruiting

Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease

Vogt Koyanagi Harada Disease

Brazil
City of Hope Medical Center
National Cancer Institute (NCI)

Terminated

Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Myelodysplastic-Myeloproliferative Diseases | Neuroblastoma | Infection | Multiple Myeloma and Plasma Cell Neoplasm | Graft Versus Host Disease | Therapy-related Toxicity

United States
Jiangsu Renocell Biotech Company
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical...

Recruiting

RY_SW01 Cell Injection Therapy in Active Lupus Nephritis

Lupus Nephritis

China
Institute of Hematology and Blood Transfusion,...
CZECRIN - Czech Clinical Research Infrastructure Network

Completed

Blinatumomab Followed by High-dose Chemotherapy for Ph-negative Acute Lymphoblastic Leukemia (ALL) (Blina-CELL)

Newly Diagnosed | Lymphoblastic Leukemia, Acute, Adult | Ph Negative ALL

Czechia
Xiaoli Fan

Recruiting

Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome

Cholangitis | Hepatitis, Autoimmune | Cholestasis | Liver Cirrhosis, Biliary

China
Thomas Wekerle
University Hospital Regensburg

Active, not recruiting

Cell Therapy for Immunomodulation in Kidney Transplantation

Kidney Transplantation

Austria
Brian Hill, MD, PhD
National Cancer Institute (NCI); The Leukemia and Lymphoma Society

Terminated

Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma

Lymphoma | 714leukemia

United States
Northern Hospital, Australia
Abbott Medical Devices

Unknown

Apposition Assessed Using Optical Coherence Tomography of Chromium Stents Eluting Everolimus From Cobalt Versus Platinum Alloy Platforms (APPOSE)

Coronary Artery Disease

Australia
National Institute of Allergy and Infectious Diseases...
Johns Hopkins University; PPD

Active, not recruiting

COVID Protection After Transplant-Immunosuppression Reduction (CPAT-ISR)

Liver Transplant Recipients | Kidney Transplant Recipients

United States
Prof. Dr. med. Wolfgang Bethge
Pfizer; medac GmbH; Neovii Biotech

Terminated

Multicenter Study of Peritransplantation Immunosuppression for Mismatched Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

Patients Receiving Mismatched Allogeneic HCT

Germany
RenJi Hospital

Unknown

Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma

Hepatocellular Carcinoma
University Hospital, Clermont-Ferrand
Pierre Fabre Laboratories

Unknown

Eradication of Residual Disease by Preemptive Immunointervention After Allogeneic Hematopoietic Stem Cells Transplantation in Chronic Lymphocytic Leukemia (RICAC)

Chronic Lymphocytic Leukemia | Lymphocytic Lymphoma

France
Fox Chase Cancer Center
Novartis Pharmaceuticals

Terminated

Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus (SAGE)

Sporadic Angiomyolipomas (AMLs)

United States
Yale University
Novartis Pharmaceuticals

Terminated

Neoadj ph 2 AI Plus Everolimus in Postmenopausal Women w/ ER Pos/HER2 Neg, Low Risk Score

Breast Cancer

United States

Search clinical trials for: Immunosuppressive Agents

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations